The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Completed

• Conditions: Major Depressive Disorders; Schizophrenia; Bipolar Disorders

• Registration Number: NCT01377896
• Lead Sponsor: AstraZeneca

Brief Summary

'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Status Verified: 2011-06
• Study First Submitted: 2011-06-14
• Study First Submitted QC: 2011-06-20
• Study First Posted: 2011-06-22
• Last Update Submitted: 2011-06-27
• Last Update Posted: 2011-06-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 221

Inclusion Criteria

• Patients diagnosed with one of the following conditions: Schizophrenia, Bipolar disorders and Major depressive disorders.

Exclusion Criteria

• Patients who have not been diagnosed with the conditions as outlined in the Inclusion criteria.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified